| Trial ID: | L1080 |
| Source ID: | NCT02888171
|
| Associated Drug: |
Ferric Citrate
|
| Title: |
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02888171/results
|
| Conditions: |
Chronic Kidney Disease|Iron Deficiency|Anemia
|
| Interventions: |
DRUG: ferric citrate|DRUG: ferrous sulfate
|
| Outcome Measures: |
Primary: Change in Ferritin From Baseline to End of Treatment, The change in serum ferritin concentrations from the baseline of the study to the 12 week time point., Baseline and 12 weeks|Change in Transferrin Saturation From Baseline to End of Treatment, The change in serum transferrin saturation from the baseline to the end of treatment, Baseline and 12 weeks | Secondary: Change in Hemoglobin From Baseline to End of Treatment, The change in hemoglobin concentrations from the baseline visit to the 12-week time point., Baseline and 12 weeks|Change in Hepcidin From Baseline to the End of Treatment, The change in hepcidin concentrations from the baseline visit to the 12-week time point., Baseline and 12 weeks|Change in Fibroblast Growth Factor 23 From Baseline to the End of Treatment, The change in fibroblast growth factor 23 concentrations from the baseline visit to the 12-week time point., Baseline and 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Alabama at Birmingham
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-09
|
| Completion Date: |
2019-03-30
|
| Results First Posted: |
2020-03-24
|
| Last Update Posted: |
2020-03-24
|
| Locations: |
University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02888171
|
